Aspirin, Caffeine, and Dihydrocodeine Bitartrate - Aspirin, Caffeine, and Dihydrocodeine Bitartrate
Navigation: NDC > Supplier starting with: C > CARACO PHARMACEUTICAL LABORATORIES, LTD| Field | Value |
|---|---|
| NDC Code: | 57664-419 |
| Proprietary Name: | Aspirin, Caffeine, and Dihydrocodeine Bitartrate |
| Suffix: | |
| Non-Proprietary Name: | Aspirin, Caffeine, and Dihydrocodeine Bitartrate |
| Dosage Form: | CAPSULE |
| Method: | ORAL |
| Original Marketing Date: | 01-10-2012 |
| Category Name: | NDA AUTHORIZED GENERIC |
| Application Number: | NDA011483 |
| Labeler: | CARACO PHARMACEUTICAL LABORATORIES, LTD |
| Substance Name: | ASPIRIN; CAFFEINE; DIHYDROCODEINE BITARTRATE |
| Active Numerator Strength: | 356.4; 30; 16 |
| Active Ingredient Unit: | mg/1; mg/1; mg/1 |
| Pharm Classes: | Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Methylxanthine [EPC],Xanthines [Chemical/Ingredient],Full Opioid Agonists [MoA],Opioid Agonist [EPC] |
| DEA Schedule: | CIII |